We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1B
AUM Growth
-$10.2M
Cap. Flow
-$19.8M
Cap. Flow %
-1.98%
Top 10 Hldgs %
3.73%
Holding
2,077
New
647
Increased
422
Reduced
386
Closed
620

Top Buys

Rank Stock Value
1
WEN icon
Wendy's
WEN
+$4.1M
2
DMC
Del Monte Corp
DMC
+$3.08M
3
SONO icon
Sonos
SONO
+$2.84M
4
IDXX icon
Idexx Laboratories
IDXX
+$2.8M
5
JBSS icon
John B. Sanfilippo & Son
JBSS
+$2.73M

Sector Composition

Rank Sector Weight
1 Technology 15.64%
2 Consumer Discretionary 14.23%
3 Healthcare 13.56%
4 Financials 11.82%
5 Industrials 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGI icon
1426
Angi Inc
ANGI
$196M
$42K ﹤0.01%
+1,267
New +$35.5K
DNMR
1427
DELISTED
Danimer Scientific, Inc.
DNMR
$39K ﹤0.01%
+406
New +$52.1K
EGIO
1428
DELISTED
Edgio, Inc. Common Stock
EGIO
$39K ﹤0.01%
1,447
-9,030
-86% -$213K
ABSI icon
1429
Absci
ABSI
$1.51B
$33K ﹤0.01%
+21,698
New +$34.9K
LU icon
1430
Lufax Holding
LU
$1.3B
$33K ﹤0.01%
5,736
-126,740
-96% -$838K
SES icon
1431
SES AI
SES
$208M
$33K ﹤0.01%
+13,449
New +$26.1K
ADAP
1432
DELISTED
Adaptimmune Therapeutics
ADAP
$32K ﹤0.01%
34,307
-14,330
-29% -$17.1K
ENSC icon
1433
Ensysce Biosciences
ENSC
$7.99M
$32K ﹤0.01%
+1,170
New +$52.9K
LUMN icon
1434
Lumen
LUMN
$6.44B
$31K ﹤0.01%
13,501
-93,126
-87% -$205K
VLN icon
1435
Valens Semiconductor
VLN
$188M
$31K ﹤0.01%
+12,387
New +$31.5K
CASA
1436
DELISTED
Casa Systems, Inc. Common Stock
CASA
$28K ﹤0.01%
+22,684
New +$26.2K
CAN
1437
Canaan Creative
CAN
$159M
$26K ﹤0.01%
12,168
-58,003
-83% -$141K
PAYS icon
1438
Paysign
PAYS
$698M
$26K ﹤0.01%
+10,448
New +$32.1K
MKFG
1439
DELISTED
Markforged Holding Corporation
MKFG
$26K ﹤0.01%
2,141
-4,012
-65% -$37.8K
AZRE
1440
DELISTED
Azure Power Global Limited
AZRE
$25K ﹤0.01%
13,877
-199,267
-93% -$436K
AQST icon
1441
Aquestive Therapeutics
AQST
$494M
$23K ﹤0.01%
+13,952
New +$25.2K
PLBY icon
1442
Playboy Inc
PLBY
$141M
$20K ﹤0.01%
+11,701
New +$19.8K
CMRX
1443
DELISTED
Chimerix, Inc.
CMRX
$20K ﹤0.01%
16,411
-2,552
-13% -$3.23K
LCTX icon
1444
Lineage Cell Therapeutics
LCTX
$274M
$19K ﹤0.01%
+13,196
New +$18.2K
ARQQ icon
1445
Arqit Quantum
ARQQ
$399M
$17K ﹤0.01%
574
-777
-58% -$23.5K
ATER icon
1446
Aterian
ATER
$5.37M
$17K ﹤0.01%
+3,029
New +$23.6K
PSHG icon
1447
Performance Shipping
PSHG
$21.8M
$17K ﹤0.01%
21,153
-27,313
-56% -$21.5K
MNTS icon
1448
Momentus
MNTS
$92.7M
$15K ﹤0.01%
+4
New +$18.8K
PRAX icon
1449
Praxis Precision Medicines
PRAX
$10.1B
$14K ﹤0.01%
+820
New +$12.6K
TOPS icon
1450
TOP Ships
TOPS
$4.24M
$14K ﹤0.01%
+2,035
New +$17.8K

Similar funds

GSA Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, GSA Capital Partners held 2,077 positions worth $1B, down 1% from $1.01B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners's Q2 2023 filing shows 647 new, 422 increased, 386 reduced and 620 closed positions. Its largest new stake was Sonos: 160,082 shares worth $2.61M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $7.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • GSA Capital Partners's largest Q2 2023 buy was Sonos: 160,082 shares worth $2.61M.
  • GSA Capital Partners added most to Wendy's in Q2 2023, an estimated $4.1M increase.
  • GSA Capital Partners's biggest Q2 2023 reduction was Arlo Technologies, cutting an estimated $3.67M.
  • GSA Capital Partners fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2023, selling an estimated $7.8M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $1B portfolio in Q2 2023.
  • GSA Capital Partners opened 647 new positions and closed 620 in Q2 2023.
  • GSA Capital Partners's portfolio value fell 1% quarter-over-quarter to $1B.

Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.